Physician profile

Hartwig O Boepple

Pulmonary Disease · Williamsville, NY

NPI 1568426344

$17,208.52

in general payments reported to CMS, 2019-2025

51 companies · $3,255 in 2025

The $3,255 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,115.91
Education$238.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $3,165.83 2019-2025 Fasenra, Airsupra, Breztri
Glaxosmithkline, LLC. $2,604.73 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Boehringer Ingelheim Pharmaceuticals, INC. $1,359.31 2019-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Genzyme Corporation $1,314.29 2019-2025
Actelion Pharmaceuticals US, INC. $1,247.82 2019-2025 Uptravi, Opsumit
Mallinckrodt Hospital Products INC. $645.16 2020-2025 Acthar
Regeneron Healthcare Solutions, INC. $605.49 2019-2025 Dupixent
Grifols USA, LLC $480.86 2019-2025 Prolastin-C Liquid
Electromed, INC. $479.33 2019-2025 Smartvest
Insmed, INC. $477.94 2019-2025 Arikayce, Brinsupri
Mylan Specialty L.P. $446.15 2020-2024 Yupelri
Amgen INC. $369.19 2021-2025 Tezspire, Repatha, Otezla
Merck Sharp & Dohme LLC $343.30 2019-2025 Winrevair, Zerbaxa, Recarbrio
Bayer Healthcare Pharmaceuticals INC. $332.97 2019-2023
Jazz Pharmaceuticals INC. $305.32 2019-2022
Show all 51 companies
CompanyGeneral paymentsYearsTop products
Takeda Pharmaceuticals U.S.A., INC. $294.92 2020-2025 Glassia
Pfizer INC. $241.16 2021-2025
Philips North America LLC $214.14 2020-2025 (Ak6) Vest Therapy, Vest Therapy Und
United Therapeutics Corporation $196.85 2020-2023 Tyvaso
Teva Pharmaceuticals USA, INC. $181.84 2019-2022
Verona Pharma, INC. $158.44 2025 Ohtuvayre
Lilly USA, LLC $150.12 2022-2023 Jardiance, Emgality
Gilead Sciences, INC. $129.18 2019-2021
Pulmonx Corporation $116.19 2023-2025 Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter
Inogen, INC. $115.32 2022-2024 Inogen One G5 Oxygen Concentrator - Bluetooth
Inspire Medical Systems, INC. $109.84 2024-2025 Inspire
Sanofi-Aventis U.S. LLC $99.99 2025
3b Medical, INC. $99.61 2024-2025 Luna
Advanced Respiratory, INC $75.01 2019-2021
Viatris Specialty LLC $74.69 2025 Yupelri
Axsome Therapeutics, INC. $62.72 2023-2024 Sunosi
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $55.76 2022-2024 Xifaxan
Kowa Pharmaceuticals America, INC. $53.51 2021-2022
Paratek Pharmaceuticals, INC. $52.07 2019-2022
Novo Nordisk INC $51.92 2021-2023 Wegovy
Vifor Pharma, INC. $49.23 2025 Zemaira, Veltassa
Circassia INC. $44.77 2019
Alexion Pharmaceuticals, INC. $44.59 2021-2022
Fisher & Paykel Healthcare INC $43.37 2022
Abbvie INC. $42.74 2022-2023 Qulipta
Genentech USA, INC. $41.82 2019
Exact Sciences Corporation $36.15 2024-2025 Cologuard Collection Kit
Portola Pharmaceuticals, LLC $32.17 2019-2020
Resmed Corp $31.19 2023
Sunovion Pharmaceuticals INC. $28.57 2019
Vanda Pharmaceuticals INC. $24.37 2021
Ani Pharmaceuticals, INC. $17.43 2024 Purified Cortrophin Gel
Kaleo, INC. $17.04 2021
Shire North American Group INC $15.97 2019
Baxter Healthcare $14.86 2023 Hillrom - Life 2000 Ventilation System
Amarin Pharma, INC. $13.28 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Hartwig O Boepple

$17,208.52

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $3,255 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/71048/hartwig-o-boepple

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.